EGFR and lung carcinoma: In another recent work, He et al. synthesized a new series of 4-indolyl quinazoline derivatives, and among this series, compound St.58 (Table 11) potently inhibits EGFR and suppresses p-EGFR and p-AKT in lung cancer cell lines.